EGF and non-small cell lung carcinoma: NSCLC-specific pathways included MAPK64,65, PI3K-Akt66, PLD36, Ras67, EGF/EGFR68–71, c-Met72–74, LPARs75, IL-476 and IL-677–79 SPs which play significant roles in tumorigenesis and cancer development.